Mulberry Extract

Provides potent skin-brightening effects through inhibition of tyrosinase, the key enzyme in melanin synthesis. Helps fade dark spots, melasma, and post-inflammatory hyperpigmentation with consistent use. Evens overall skin tone by reducing melanin overproduction in hyperactive melanocytes. Offers antioxidant protection through oxyresveratrol and flavonoid compounds that neutralize free radicals. Provides anti-inflammatory support that addresses the inflammatory triggers underlying many forms of hyperpigmentation. Demonstrates a favorable safety profile compared to synthetic depigmenting agents such as hydroquinone.

Incorporate mulberry extract into your routine through serums, essences, or targeted treatment products designed for hyperpigmentation. Apply to cleansed skin in the evening, or both morning and evening for accelerated results. Layer under moisturizer and always use broad-spectrum sunscreen during the day, as unprotected sun exposure will counteract brightening efforts. For best results, combine with other complementary brightening ingredients such as niacinamide, vitamin C, or alpha-arbutin. Consistent use for a minimum of eight to twelve weeks is generally needed to observe significant improvements in pigmentation. Products with mulberry extract listed in the first half of the ingredient list are more likely to contain effective concentrations.

Research published in the Journal of Cosmetic Dermatology demonstrated that mulberry extract inhibited tyrosinase activity by approximately 50% at concentrations achievable in topical formulations, comparable to kojic acid at equivalent doses. A comparative in vitro study found that oxyresveratrol was 32 times more potent than arbutin in tyrosinase inhibition. Clinical studies have shown that mulberry-containing formulations significantly reduced the Melanin Index and improved subjective assessments of skin brightness after 8 to 12 weeks of use. A study in the International Journal of Molecular Sciences characterized the multiple mechanisms by which mulberry phenolics inhibit melanogenesis, including direct tyrosinase binding, downregulation of MITF, and reduction of oxidative stress in melanocytes. However, one of the challenges with mulberry extract is the variability in active compound concentration depending on the plant part used and extraction method. Standardization of preparations to specific oxyresveratrol or mulberroside A content would improve clinical reproducibility.